Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corvita
- Development stage
- Unknown
- Lead developer
- Trigen Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Corvita is a prescription multivitamin and mineral supplement developed by Trigen Laboratories. It is formulated to provide nutritional support, particularly for individuals with iron deficiency or those at risk of anemia. The product contains a combination of Carbonyl Iron, Vitamin C (ascorbic acid), Vitamin E, Vitamin B6 (pyridoxine), Vitamin B12 (cyanocobalamin), and Folic Acid. The inclusion of Vitamin C is intended to enhance the gastrointestinal absorption of iron. Corvita is typically used to treat or prevent nutrient deficiencies caused by certain illnesses, pregnancy, poor nutrition, or digestive disorders.
- Brand names
- CorvitaCorvita 150Corvita150Corvita-150
- Other names
- Corvita
Beyond the preview
Go deeper on Corvita.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corvita.